Back to Home
Live Credit Evaluation

PI3K/AKT Simulation Sprint: Optimizing Pathway-Targeted Therapy in HR+ Metastatic Breast Cancer

Release Date

July 14, 2026

Expiration Date

September 15, 2026

Credits

1.25 Credits

No content available for this section.

Supporter statement here

What's Included
  • Access your activities anytime, anywhere, with a computer, tablet or smartphone
  • Free access with a PTCE account
  • Pharmacy education designed to improve patient care

Follow Us on Social Media!

Course

PI3K/AKT Simulation Sprint: Optimizing Pathway-Targeted Therapy in HR+ Metastatic Breast Cancer

Create Account